Table I.
Characteristics of the study population
| No.(Total=106) | % | |
|---|---|---|
| Age (years) | ||
| 18–29 | 14 | 14.2% |
| 30–39 | 24 | 24.5% |
| 40–49 | 24 | 24.5% |
| 50–59 | 28 | 28.5% |
| 60–69 | 7 | 7.3% |
| > 70 | 1 | 1% |
| Age diagnosed with Psoriasis | ||
| <10 | 5 | 5.10% |
| 10-19 | 34 | 34.69% |
| 20-29 | 36 | 36.73% |
| 30-39 | 10 | 10.52% |
| 40-49 | 9 | 9.18% |
| 50-59 | 2 | 2.04% |
| 60-69 | 1 | 1.02% |
| >70 | 1 | 1.02% |
| Psoriatic Arthritis | ||
| Yes | 40 | 40.4% |
| No | 50 | 50.5% |
| Not Sure | 9 | 9.1% |
| Gender | ||
| Male | 58 | 58.6% |
| Female | 41 | 41.4% |
| Race | ||
| White | 58 | 58.6% |
| African American | 0 | 0.0% |
| Hispanic | 5 | 5.1% |
| Asian/Pacific Islander | 32 | 32.3% |
| Native American | 1 | 1.0% |
| Other | 3 | 3.03% |
| Education | ||
| Less than high school | 0 | 0.0% |
| High school graduate | 14 | 14.1% |
| Undergraduate | 51 | 51.5% |
| Graduate | 34 | 34.3% |
| Living area | ||
| Urban | 66 | 66.7% |
| Suburban | 30 | 30.3% |
| Rural | 3 | 3.0% |
| Household income ($) | ||
| < 15,000 | 8 | 8.4% |
| 15,000–40,000 | 8 | 8.4% |
| 40,001–60,000 | 13 | 13.7% |
| 60,001-100,000 | 26 | 27.4% |
| >100,001 | 40 | 42.1% |
| Health insurance | ||
| Yes | 92 | 92.9% |
| No | 7 | 7.1% |
| Number of Biologics used | ||
| 1 | 50 | 48.5% |
| 2 | 33 | 32.0% |
| 3 | 13 | 12.6% |
| > 3 | 7 | 6.8% |
| Biologics Currently Using | ||
| Amevive | 2 | |
| Raptiva | 0 | |
| Enbrel | 30 | |
| Humira | 48 | |
| Remicade | 3 | |
| Stelara | 4 | |
| Simponi | 0 | |
| Biologics Previously Using | ||
| Amevive | 12 | |
| Raptiva | 13 | |
| Enbrel | 44 | |
| Humira | 18 | |
| Remicade | 7 | |
| Stelara | 2 | |
| Simponi | 2 | |
| Biologics currently using or previously used | ||
| No. (n=103) | % | |
| Amevive | 13 | 12.6% |
| Raptiva | 13 | 12.6% |
| Enbrel | 72 | 69.9% |
| Humira | 64 | 62.1% |
| Remicade | 10 | 9.7% |
| Stelara | 6 | 5.8% |
| Simponi | 2 | 1.9% |
| Duration of medication use by number of patients | |||
| Less than 3 months | 3 months to 1 year | Greater than 1 year | |
| Amevive | 4 | 5 | 4 |
| Raptiva | 2 | 1 | 10 |
| Enbrel | 7 | 16 | 50 |
| Humira | 10 | 15 | 38 |
| Remicade | 4 | 1 | 5 |
| Stelara | 1 | 3 | 1 |
| Simponi | 1 | 1 | 0 |